Carefusion Corporation (CFN)
January 09, 2012 9:00 am ET
Kieran T. Gallahue - Chairman and Chief Executive Officer
James F. Hinrichs - Chief Financial Officer
Jim Mazzola - Senior Vice President of Global Marketing and Communication
Lennox Ketner - BofA Merrill Lynch, Research Division
Michael N. Weinstein - JP Morgan Chase & Co, Research Division
Amit Bhalla - Citigroup Inc, Research Division
David H. Roman - Goldman Sachs Group Inc., Research Division
Matthew Taylor - Barclays Capital, Research Division
Kristen M. Stewart - Deutsche Bank AG, Research Division
David R. Lewis - Morgan Stanley, Research Division
Good day, ladies and gentlemen, and welcome to the CareFusion Corporation Investor Meeting. My name is Pamela, and I'll be your operator for today. [Operator Instructions] As a reminder, this call is being recorded for replay purposes. At this time, I would like to turn the conference over to Mr. Jim Mazzola. Please proceed.
Thank you, Pamela. This is Jim Mazzola, and thanks for joining us on today's call as we discuss CareFusion's preliminary results for the second fiscal quarter ended December 31, 2011, and provide updated guidance for our fiscal 2012.
We issued a news release containing our preliminary financial results this morning at 8:00 a.m. Eastern time, which is posted in our website at carefusion.com and filed on Form 8-K with the SEC. Joining me on today's call are Kieran Gallahue, our Chairman and CEO; and Jim Hinrichs, our CFO.
Before I turn the call over to Kieran, I would like to make a few remarks. In today's call, we will discuss some non-GAAP financial measures, including financial results on an adjusted basis. A reconciliation to GAAP measures can be found in today's release and on the Investors section of our website. We believe these adjusted financial measures can facilitate a more complete analysis and greater transparency into CareFusion's ongoing results of operations, particularly in comparing underlying results from period to period.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts